PortfoliosLab logoPortfoliosLab logo
HRMY vs. SPY
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

HRMY vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Harmony Biosciences Holdings, Inc. (HRMY) and State Street SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HRMY achieves a -5.83% return, which is significantly lower than SPY's 10.13% return.


HRMY

1D
-1.73%
1M
-5.42%
6M
-3.50%
YTD
-5.83%
1Y
2.44%
3Y*
1.21%
5Y*
6.14%
10Y*
ALL TIME*
-2.10%

SPY

1D
0.72%
1M
0.30%
6M
8.53%
YTD
10.13%
1Y
21.49%
3Y*
19.32%
5Y*
12.76%
10Y*
15.07%
ALL TIME*
10.79%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$30.21M$30.03M$28.08M
$37.27B$35.99B$39.23B

HRMY vs. SPY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
HRMY
Harmony Biosciences Holdings, Inc.
-5.83%8.75%6.53%-41.38%29.22%17.95%-9.60%
SPY
State Street SPDR S&P 500 ETF
10.13%17.72%24.89%26.18%-18.18%28.73%11.32%

Correlation

The correlation between HRMY and SPY is 0.18, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.18

Correlation (3Y)
Balances recent behavior with more history.

0.28

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.33

Correlation (All Time)
Calculated using the full available price history since Aug 19, 2020

0.31

The correlation between HRMY and SPY shifts across timeframes, from 0.18 (1 year) to 0.33 (5 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HRMY vs. SPY — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

HRMY
HRMY Risk / Return Rank: 4343
Overall Rank
HRMY Sharpe Ratio Rank: 4444
Sharpe Ratio Rank
HRMY Sortino Ratio Rank: 4141
Sortino Ratio Rank
HRMY Omega Ratio Rank: 4242
Omega Ratio Rank
HRMY Calmar Ratio Rank: 4444
Calmar Ratio Rank
HRMY Martin Ratio Rank: 4444
Martin Ratio Rank

SPY
SPY Risk / Return Rank: 6767
Overall Rank
SPY Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
SPY Sortino Ratio Rank: 6464
Sortino Ratio Rank
SPY Omega Ratio Rank: 6565
Omega Ratio Rank
SPY Calmar Ratio Rank: 6464
Calmar Ratio Rank
SPY Martin Ratio Rank: 7676
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

HRMY vs. SPY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Harmony Biosciences Holdings, Inc. (HRMY) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HRMYSPYDifference
Sharpe ratioReturn per unit of total volatility

-1.52

Sortino ratioReturn per unit of downside risk

-1.81

Omega ratioGain probability vs. loss probability

1.04

1.27

-0.23

Calmar ratioReturn relative to maximum drawdown

0.01

2.20

-2.20

Martin ratioReturn relative to average drawdown

0.01

9.40

-9.39

HRMY vs. SPY - Sharpe Ratio Comparison

The current HRMY Sharpe Ratio is 0.00, which is lower than the SPY Sharpe Ratio of 1.52. The chart below compares the historical Sharpe Ratios of HRMY and SPY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

HRMY vs. SPY - Drawdown Comparison

The maximum HRMY drawdown since its inception was -68.48%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for HRMY and SPY.


Loading charts...

Drawdown Indicators


HRMYSPYDifference

Max Drawdown

Largest peak-to-trough decline

-68.48%

-55.19%

-13.29%

Max Drawdown (1Y)

Largest decline over 1 year

-34.49%

-8.88%

-25.61%

Max Drawdown (3Y)

Largest decline over 3 years

-50.81%

-18.76%

-32.05%

Max Drawdown (5Y)

Largest decline over 5 years

-68.48%

-24.50%

-43.98%

Max Drawdown (10Y)

Largest decline over 10 years

-33.72%

Current Drawdown

Current decline from peak

-42.14%

-1.40%

-40.74%

Average Drawdown

Average peak-to-trough decline

-35.42%

-9.01%

-26.41%

Ulcer Index

Depth and duration of drawdowns from previous peaks

19.24%

2.08%

+17.16%

Volatility

HRMY vs. SPY - Volatility Comparison

Harmony Biosciences Holdings, Inc. (HRMY) has a higher volatility of 14.79% compared to State Street SPDR S&P 500 ETF (SPY) at 3.58%. This indicates that HRMY's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HRMYSPYDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.79%

3.58%

+11.21%

Volatility (6M)

Calculated over the trailing 6-month period

32.46%

10.14%

+22.32%

Volatility (1Y)

Calculated over the trailing 1-year period

43.31%

12.89%

+30.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

50.15%

17.18%

+32.97%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

52.28%

17.95%

+34.33%

Dividends

HRMY vs. SPY - Dividend Comparison

HRMY has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.01%.


PositionTTM20252024202320222021202020192018201720162015
HRMY
Harmony Biosciences Holdings, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
State Street SPDR S&P 500 ETF
1.01%1.07%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%

Frequently Asked Questions


HRMY and SPY have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HRMY has higher volatility (14.79%) compared to SPY (3.58%). In terms of maximum drawdown, HRMY dropped -68.48% vs SPY's -55.19%.

SPY currently has the higher Sharpe Ratio (1.52 vs 0.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HRMY and SPY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer